Prestige Consumer Healthcare Files 8-K on Director Changes & Compensation
Ticker: PBH · Form: 8-K · Filed: Jan 6, 2025 · CIK: 1295947
| Field | Detail |
|---|---|
| Company | Prestige Consumer Healthcare Inc. (PBH) |
| Form Type | 8-K |
| Filed Date | Jan 6, 2025 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.01, $700,000, b, $1,575,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: governance, executive-compensation, board-changes
Related Tickers: PCMH
TL;DR
Prestige Consumer Healthcare (PCMH) filed an 8-K detailing director changes and executive pay. Governance update.
AI Summary
Prestige Consumer Healthcare Inc. filed an 8-K on January 6, 2025, reporting on the departure of a director, the election of a new director, and compensatory arrangements for certain officers. The filing also includes financial statements and exhibits.
Why It Matters
This filing provides insight into the company's governance and executive compensation structure, which can influence investor confidence and strategic direction.
Risk Assessment
Risk Level: low — This is a routine corporate filing detailing board and executive changes, not indicating immediate financial distress or significant operational shifts.
Key Players & Entities
- Prestige Consumer Healthcare Inc. (company) — Registrant
- January 6, 2025 (date) — Date of earliest event reported
- 660 White Plains Road, Tarrytown, New York 10591 (address) — Principal Executive Office Address
FAQ
Who departed from the board of directors?
The filing indicates the departure of a director, but the specific name is not provided in the excerpt.
Was a new director elected?
Yes, the filing reports the election of a director.
What other items are covered in this 8-K filing?
The filing also covers compensatory arrangements of certain officers and includes financial statements and exhibits.
What is the company's fiscal year end?
The company's fiscal year ends on March 31st.
What is the company's SIC code?
The company's Standard Industrial Classification (SIC) code is 2834, Pharmaceutical Preparations.
Filing Stats: 806 words · 3 min read · ~3 pages · Grade level 10.5 · Accepted 2025-01-06 08:00:30
Key Financial Figures
- $0.01 — ch registered Common stock, par value $0.01 per share PBH New York Stock Exchange
- $700,000, b — o will receive an annual base salary of $700,000, be eligible for target annual cash incent
- $1,575,000 — ive Plan with a targeted award value of $1,575,000 allocated sixty percent (60%) of the ta
Filing Documents
- tm251576d1_8k.htm (8-K) — 27KB
- tm251576d1_ex99-1.htm (EX-99.1) — 5KB
- 0001104659-25-001076.txt ( ) — 204KB
- pbh-20250106.xsd (EX-101.SCH) — 3KB
- pbh-20250106_lab.xml (EX-101.LAB) — 33KB
- pbh-20250106_pre.xml (EX-101.PRE) — 22KB
- tm251576d1_8k_htm.xml (XML) — 3KB
02 Departure of Directors or Principal Officers; Election
Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers On January 6, 2025, Prestige Consumer Healthcare Inc. (the "Company") announced that the Company's Chief Financial Officer, Christine Sacco, age 49, has also been appointed Chief Operating Officer, effective January 6, 2025. A copy of the press release announcing Ms. Sacco's expanded role is attached hereto as Exhibit 99.1 and incorporated herein by reference. Christine Sacco was appointed to the position of Chief Financial Officer for the Company in September 2016. Ms. Sacco joined the Company from Boulder Brands, Inc., a health and wellness food manufacturer, where she served as the Chief Financial Officer and Treasurer from January 2012 to January 2016 and Vice President and Controller from January 2008 to January 2012, including Principal Accounting Officer from January 2011 to March 2012. From October 2002 until January 2008, she held positions of increasing financial responsibility with Alpharma, Inc., a global specialty pharma company, where she last held the position of Vice President, Treasurer. Ms. Sacco began her career with Ernst & Young and worked for five years in the Audit and Assurance group. She holds a B.S. in accounting from St. Thomas Aquinas College and has been a licensed CPA. In connection with this expanded role, Ms. Sacco will receive an annual base salary of $700,000, be eligible for target annual cash incentive of 75% of her base salary and be eligible to receive annual equity awards under our Long-Term Incentive Plan with a targeted award value of $1,575,000 allocated sixty percent (60%) of the targeted equity award value to performance stock units, and forty percent (40%) to restricted stock units. In addition, Ms. Sacco received a time-based restricted stock unit ("RSU") retention award with an aggregate value of $1,575,000. The retention award RSUs granted to Ms. Sacco cliff vest in full, four years after the date of gra
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. See Exhibit Index immediately following the signature page.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: January 6, 2025 PRESTIGE CONSUMER HEALTHCARE INC. By: /s/ William P'Pool William P'Pool Sr. Vice President, General Counsel and Corporate Secretary EXHIBIT INDEX Exhibit Description 99.1 Press Release dated January 6, 2025 announcing Chief Financial Officer Christine Sacco's expanded role (furnished only). 104 Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document).